Filing Flows › Petmed Express (PETS) › Q3 FY25
Petmed Express (PETS) Q3 FY25 earnings results (third quarter fiscal 2025)
10-Q filed Feb 10, 2025
Petmed Express (PETS) reported revenue of $52.0M for the third quarter fiscal 2025 (Q3 FY25), -20% from a year earlier and -10% from the quarter before. Operating margin was -0.9%, net loss $707K (1.4% of revenue).
Petmed Express, Q3 FY25: revenue $52.0M (-20% year over year), operating margin -0.9%, net loss $707K, operating cash flow −$1.2M. The chart follows the revenue to costs, profit and cash.
| Q3 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $52.0M | -10% | -20% |
| Operating profit | −$450K | — | — |
| Net earnings | −$707K | — | — |
| Operating cash flow | −$1.2M | — | — |
What changed
Revenue was $52.0M in Q3 FY25, down 20% year over year and down 10% from the previous quarter.
Gross margin was 28.7%, up 1.3 points from a year earlier. Operating costs exceeded revenue by $450K, an operating margin of -0.9%. Operating expenses fell 27% while revenue fell 20%. The quarter ended with a net loss of $707K, after a profit of $2.3M the previous quarter. Non-operating items added $208K, -86% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$1.2M. Non-cash charges added back $1.6M of depreciation and amortization and $500K of share-based compensation. Working capital and other items used $2.5M. Capital expenditures of $777K exceeded it, leaving free cash flow of −$1.9M.
Questions
What was Petmed Express' revenue in the third quarter fiscal 2025?
Petmed Express (PETS) reported revenue of $52.0M for the third quarter fiscal 2025 (Q3 FY25), -20% from a year earlier and -10% from the quarter before.
Was Petmed Express profitable in the third quarter fiscal 2025?
Operating loss was $450K (-0.9% of revenue) and net loss $707K.
Source: Petmed Express 10-Q on SEC EDGAR.